VIA
CVAC

Virtus Investment Advisers’s CureVac CVAC Stock Holding History

Virtus Investment Advisers’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,319
Closed -$110K – 486
2025
Q3 		$110K Buy
20,319
+3,527
+21% +$19.1K 0.03% 414
2025
Q2 		$91.2K Sell
16,792
-34,504
-67% -$137K 0.03% 373
2025
Q1 		$142K Buy
+51,296
New +$178K 0.04% 349

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Virtus Investment Advisers's CVAC Position: Q4 2025 in Review

Virtus Investment Advisers sold out of CureVac (CVAC) in Q4 2025, closing a stake of 20,319 shares — an estimated $110K sold.

Virtus Investment Advisers first reported a position in CVAC in Q1 2025 and held it in 3 quarters. The position peaked at $142K in Q1 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Virtus Investment Advisers reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 20,319 CureVac shares in Q4 2025, an estimated $110K.
  • Virtus Investment Advisers first reported a position in CureVac in Q1 2025 and held it in 3 quarters.
  • Virtus Investment Advisers's CureVac position peaked at $142K in Q1 2025.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Virtus Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.